NCT02390141View on ClinicalTrials.gov

Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Hypoglycemia
Interventions
DRUG

ZP4207

DRUG

Placebo

Trial Locations (1)

41460

Profil GmbH, Neuss

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY